Betulinic acid restores imatinib sensitivity in BCR‐ABL1 kinase−independent, imatinib‐resistant chronic myeloid leukemia by increasing HDAC3 ubiquitination and degradation.

Autor: Lu, Tingting1,2,3 (AUTHOR), Wei, Danna1,4,5 (AUTHOR), Yu, Kunlin1,4,5,6 (AUTHOR), Ma, Dan1,4,5 (AUTHOR), Xiong, Jie1,4,5 (AUTHOR), Fang, Qin6 (AUTHOR), Wang, Jishi1,4,5 (AUTHOR) wangjishi9646@163.com
Zdroj: Annals of the New York Academy of Sciences. May2020, Vol. 1467 Issue 1, p77-93. 17p. 1 Chart, 7 Graphs.
Databáze: Academic Search Ultimate
Nepřihlášeným uživatelům se plný text nezobrazuje